GLENMARK LIFE SCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 830.8 INR | +0.58% |
|
+1.26% | +26.43% |
| 05-15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| 04-25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLENMARK LIFE SCIENCES LIMITED | Other Pharmaceuticals | +0.58% | +1.26% | +26.43% | +50.16% | - | 1.22B | - | - | - |
